Cellular Accumulation and Activity of Quinolones in Ciprofloxacin-Resistant J774 Macrophages

ABSTRACT Ciprofloxacin is the substrate for a multidrug resistance-related protein (MRP)-like multidrug transporter in J774 mouse macrophages, which also modestly affects levofloxacin but only marginally affects garenoxacin and moxifloxacin (J.-M. Michot et al., Antimicrob. Agents Chemother. 49:2429-2437, 2005). Two clones of ciprofloxacin-resistant cells were obtained by a stepwise increase in drug concentration (from 34 to 51 to 68 mg/liter) in the culture fluid. Compared to wild-type cells, ciprofloxacin-resistant cells showed (i) a markedly reduced ciprofloxacin accumulation (12% of control) and (ii) a two- to threefold lower sensitivity to the enhancing effect exerted by MRP-inhibitors (probenecid and MK571) on ciprofloxacin accumulation or by ciprofloxacin itself. ATP-depletion brought ciprofloxacin accumulation to similarly high levels in both wild-type and ciprofloxacin-resistant cells. Garenoxacin and moxifloxacin accumulation remained unaffected, and levofloxacin showed an intermediate behavior. DNA and protein synthesis were not impaired in ciprofloxacin-resistant cells for ciprofloxacin concentrations up to 100 mg/liter (∼85 and 55% inhibition, respectively, in wild-type cells). In Listeria monocytogenes-infected ciprofloxacin-resistant cells, 12-fold higher extracellular concentrations of ciprofloxacin were needed to show a bacteriostatic effect in comparison with wild-type cells. The data suggest that the resistance mechanism is mediated by an overexpression and/or increased activity of the MRP-like ciprofloxacin transporter expressed at a basal level in wild-type J774 macrophages, which modulates both the intracellular pharmacokinetics and activity of ciprofloxacin.

[1]  P. Tulkens,et al.  Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages , 2005, Antimicrobial Agents and Chemotherapy.

[2]  P. Tulkens,et al.  Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like Transporter , 2004, Antimicrobial Agents and Chemotherapy.

[3]  S. Cole,et al.  The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. , 2004, Current drug metabolism.

[4]  Zhonggui He,et al.  Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[5]  A. Forsgren,et al.  Several gene programs are induced in ciprofloxacin‐treated human lymphocytes as revealed by microarray analysis , 2003, Journal of leukocyte biology.

[6]  D. Schadendorf,et al.  Study of the development of chemoresistance in melanoma cell lines using proteome analysis , 2003, Electrophoresis.

[7]  P. Tulkens,et al.  Antibiotic efflux pumps in eukaryotic cells: occurrence and impact on antibiotic cellular pharmacokinetics, pharmacodynamics and toxicodynamics. , 2003, The Journal of antimicrobial chemotherapy.

[8]  P. Tulkens,et al.  Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. , 2003, The Journal of antimicrobial chemotherapy.

[9]  P. Courtoy,et al.  Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts. , 2001, European journal of cell biology.

[10]  E. Balzi,et al.  Antibiotic efflux pumps. , 2000, Biochemical pharmacology.

[11]  C. Tei,et al.  Interactions of Ofloxacin and Erythromycin with the Multidrug Resistance Protein (MRP) in MRP-Overexpressing Human Leukemia Cells , 2000, Antimicrobial Agents and Chemotherapy.

[12]  T. Seay,et al.  Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. , 1996, The Journal of urology.

[13]  R. Echols,et al.  Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers , 1993, Antimicrobial Agents and Chemotherapy.

[14]  D. Cohen,et al.  Probenecid-resistant J774 cell expression of enhanced organic anion transport by a mechanism distinct from multidrug resistance. , 1993, Infectious agents and disease.

[15]  T. Ishikawa,et al.  MDR and MRP gene families as cellular determinant factors for resistance to clinical anticancer agents. , 2002, Cancer treatment and research.

[16]  I. Pastan,et al.  Selection and maintenance of multidrug-resistant cells. , 1998, Methods in enzymology.

[17]  John Calvin Reed,et al.  Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells , 1997, Leukemia.

[18]  S. Gollapudi,et al.  Difloxacin reverses multidrug resistance in HL-60/AR cells that overexpress the multidrug resistance-related protein (MRP) gene. , 1995, Oncology research.

[19]  P. Tulkens,et al.  Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages. , 1990, The Journal of antimicrobial chemotherapy.

[20]  Steven J. Steindel,et al.  4 Lactate Dehydrogenase , 1975 .